Ethan R. Goldman

Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…

Davis Polk advised Track & Field Co S.A. and the selling shareholders in connection with Track & Field’s initial public offering of 49,166,000 preferred shares for an aggregate…

Davis Polk advised the representatives of the several underwriters in connection with the $1.3 billion initial public offering of 39,807,691 shares of Class A common stock of GoodRx…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,200,000 shares of common stock of…

We advised Sterling Equities on the sale

Davis Polk advised Empreendimentos Pague Menos S.A. (“Pague Menos”) in connection with its initial public offering of 87,873,463 common shares for an aggregate amount of R$746.9 million …

Davis Polk advised the initial purchasers in connection with the offering by Empresa de los Ferrocarriles del Estado (EFE) of $500 million aggregate principal amount of its 3.068%…

Davis Polk advised the joint book-running managers on a Rule 144A / Regulation S offering by Wyndham Hotels & Resorts, Inc. of $500 million aggregate principal amount of 4.375%…

Davis Polk advised the underwriters on the registered offering of $700 million aggregate principal amount of 1.100% notes due 2030 and $300 million aggregate principal amount of 2.000%…

Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Turning Point Therapeutics, Inc. of its common stock for up to an aggregate amount of $250 million…